organization

FOUNDATION LYGATURE

STICHTING LYGATURE
18 projects, page 1 of 4
  • project . 2018 - 2022
    Funder: EC Project Code: 779316
    Overall Budget: 5,357,030 EURFunder Contribution: 5,357,030 EUR
    Open Access mandate for Publications and Research Data
    Partners: Clinica Universidad de Navarra, Stichting Sanquin Bloedvoorziening, ICS, ICOMETRIX NV, FOUNDATION LYGATURE, WWU, University of Antwerp, UZA

    Multiple sclerosis (MS) is an inflammatory neurodegenerative disease of the central nervous system for which no cure is currently available. It is the leading cause of non-traumatic disabling neurological disease in young adults with more than 500,000 people affected in...

  • project . 2019 - 2022
    Funder: EC Project Code: 820880
    Overall Budget: 2,131,610 EURFunder Contribution: 999,698 EUR
    Open Access mandate for Publications and Research Data
    Partners: NORGES PARKINSONFORBUND, KCL, Ud'A, ASTRAZENECA AB, FOUNDATION LYGATURE, MU, STAVANGER UNIVERSITETSSJUKEHUS, TUD, University of Exeter, PARKINSON'S UK

    Parkinson Disease (PD) is the second most common neurodegenerative disease after Alzheimer’s disease. There is an unmet clinical need to treat Parkinson disease with mild cognitive impairment (PD-MCI). There is ample evidence from epidemiological studies as well as (pre...

  • project . 2019 - 2025
    Funder: EC Project Code: 853979
    Overall Budget: 31,416,000 EURFunder Contribution: 12,300,000 EUR
    Open Access mandate for Publications
    Partners: INSERM, University of Liverpool, NOSOPHARM, Medical University of Vienna, BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE, ERASMUS MC, Fraunhofer, NBT, FOUNDATION LYGATURE, EVOTEC INTERNATIONAL GMBH...

    AntiMicrobial Resistance (AMR) is a global and serious threat to human health. Gram-negative bacteria are widely regarded as the culprit representing one of the gravest dangers. Indeed, there is a dearth of new agents able to address AMR in Gram-negative bacteria, espec...

  • project . 2014 - 2018
    Funder: EC Project Code: 602666
    Open Access mandate for Publications Special Clause 39
    Partners: STICHTING VU, Fraunhofer, CSIC, EUROPEAN SCREENINGPORT GMBH, TBRI, University of Kent, University of Antwerp, FOUNDATION LYGATURE, IOTA PHARMACEUTICALS LTD, FIOCRUZ...
  • project . 2019 - 2022
    Funder: EC Project Code: 806999
    Overall Budget: 7,644,400 EURFunder Contribution: 4,999,760 EUR
    Open Access mandate for Publications
    Partners: STICHTING VUMC, UOXF, SOFTWARE AG, Karolinska Institutet Innovations (Sweden), Eli Lilly and Company Limited, ALTOIDA SA ALTOIDA LTD, AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN, Fraunhofer, Novartis Pharma AG, KCL...

    There is an urgent need for novel approaches assessing functional decline in early AD. The main goal of the RADAR-AD project is to develop a digital platform to detect subtle functional deficits in early Alzheimer’s disease (AD) individuals by integrating a meaningful c...

18 projects, page 1 of 4
Any information missing or wrong?Report an Issue